分享好友 资讯首页 频道列表

Clearlake Capital Announces Partnership with Databricks to Advance AI-Enabled Investing and Portfolio Value Creation

2026-07-16 11:2210680

Partnership combines the Databricks platform with West Monroe's implementation expertise to help Clearlake build an “investment firm of the future” data platform across deal origination, due diligence, fund operations, and portfolio company transformation

SANTA MONICA, Calif.--(BUSINESS WIRE)--Clearlake Capital Group, L.P. ("Clearlake"), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced a partnership with Databricks, the Data and AI company, and West Monroe, a global business and technology consulting firm, to accelerate Clearlake’s portfolio companies’ adoption of data, analytics, and AI capabilities.

Through the collaboration, Clearlake aims to connect investment, operational, financial, and portfolio data in a secure and scalable environment that accelerates enterprise-wide adoption of AI, drives productivity, and delivers measurable outcomes across the investment lifecycle from deal origination and due diligence to portfolio monitoring and value creation. By pairing cutting-edge technology with deep operational support, the partnership endeavors to help Clearlake’s portfolio companies stay ahead of industry disruption and build durable competitive advantage.

“Data and AI are increasingly becoming the core drivers of operational performance, better decision-making, and competitive advantage,” said Tony La Rosa, Managing Director, Technology and O.P.S.® at Clearlake. “This partnership brings together the Databricks platform, West Monroe's implementation expertise, and Clearlake’s O.P.S.® (Operations, People, Strategy) framework to enhance our investment process leveraging AI technologies. The partnership also aims to help our portfolio companies accelerate growth by giving management teams access to modern data infrastructure and practical AI solutions needed to improve productivity, enhance customer engagement, and create durable long-term value.”

“Investment teams in private markets are sitting on a wealth of proprietary data across deal origination, due diligence, fund operations, and portfolio company transformation, but connecting that into a coherent advantage has always been the hard part,” said Andrea DeSosa, Global Head of Capital Markets GTM at Databricks. “By partnering with Databricks and West Monroe, Clearlake is creating a stronger foundation for teams to move faster and act with more confidence, turning proprietary data into context for better decisions with the governance and controls needed to scale AI across the firm.”

“The next generation of private equity value creation will be defined by firms that can connect investment thesis, diligence insights, operational data, and AI-enabled execution,” said Keith Campbell, Global Mergers & Acquisitions and Private Equity Lead at West Monroe, a Databricks Gold Partner that helps clients build modern lakehouse and AI-ready data platforms in just weeks. “Clearlake is positioning data as an operating capability, not just a technology asset, and that mindset can create meaningful advantages from deal origination through exit.”

As part of the initiative, Clearlake also plans to bring Databricks’ capabilities to portfolio companies through its Clearlake AI Labs initiative to help management teams modernize their data infrastructure, with a focus on identifying high-impact AI use cases, building scalable data foundations, and deploying solutions that support measurable business outcomes.

About Clearlake

Clearlake Capital is a leading global alternative asset manager founded in 2006 with over $185 billion of assets under management. Clearlake offers a broad range of investment solutions across private equity, credit, infrastructure, secondaries, co-investments, and other related private market strategies. Through Pathway Capital Management, a division of Clearlake, the firm serves institutional and wealth investors seeking diversified access to private markets. Clearlake seeks to partner with experienced management teams by providing patient, long-term capital to businesses across multiple sectors. The firm aims to drive value through its active, hands-on operating approach, O.P.S.® (Operations, People, Strategy), which combines deep operational expertise with strategic and talent-focused initiatives. Headquartered in Santa Monica, Clearlake maintains 14 offices across the Americas, Europe, Asia, and the Middle East. For more information, please visit clearlake.com or follow us on LinkedIn.

About West Monroe

West Monroe is an AI-native global consulting firm built for today’s pace of change. We combine deep industry expertise with modern technology and business transformation capabilities to help organizations move faster, create value, and deliver measurable impact. We don’t just talk about what’s possible—we apply AI and technology where it matters most, pairing strategic insights with hands-on execution to help clients move from strategy to results, faster.

Clients tell us we show up differently. Our employee ownership model fuels an all-in approach grounded in practical execution, measurable impact, and lasting partnership. That commitment has earned recognition from Forbes and Business Insider and made West Monroe one of only 22 companies recognized worldwide for building high-quality careers. See what’s possible at westmonroe.com.

 

Contacts

Media Contacts:

For Clearlake
Tasha Pelio
Tasha.pelio@clearlake.com
310-400-8879

For West Monroe
Christina Galoozis
Director, External Communications
cgaloozis@westmonroe.com
847-302-1762

 
反对 0
举报 0
收藏 0
打赏 0
评论 0
VIVERE Group選擇Rimini Street強化SAP支援,加速企業轉型
總部位於印尼的整合室內設計與家具解決方案供應商,藉由專業SAP支援,取得更大的自主權與強大執行能力,以自身節奏推動企業轉型 拉斯維加斯--(美國商業資訊)-- Rimini Street, Inc. (Nasdaq: RMNI)是提供軟體支援與Agentic AI ERP的公司™,也是Oracle、SAP與VMware軟體領先的第三方支援服務供應商。該公司今日宣布,印尼領先的一站式室內工程、家具製造及家居陳設解決方案供應商VIVERE Group已選擇採用Rimini Suppor...

0评论2026-07-161722

Agenus宣布最高达3.4亿美元的超额认购私募融资,以推进针对MSS结肠癌新辅助治疗方案BOT+BAL的ROBBIN注册性临床试验
预计8500万美元的前期融资,加上行权后最高可达2.55亿美元的认购权证资金,将用于资助Agenus针对微卫星稳定型(MSS)结肠癌的新辅助治疗药物博滕西利单抗(botensilimab)和巴尔斯利单抗(balstilimab)(BOT+BAL)的III期注册临床试验ROBBIN1, 该交易的结构旨在为Agenus提供资金,以支持其度过关键的价值转折点,包括中期核心病理缓解数据以及中期和最终无事件生存期(EFS)分析;假设认股权证被全部行权,所得款项将用于支持Agenus的运营直至2031...

0评论2026-07-161648

L&T Technology Services与Anthropic达成合作,为产品和制造领域提供AI驱动的工程智能
核心亮点: LTTS加入Claude合作伙伴网络,将Claude模型整合至其工程智能平台,包括AgenticIQ、PlxAI、Ainfonix、AiNexus和AiTest LTTS利用Claude帮助企业客户重塑工程工作流、加速创新并开拓新的收入机会 旧金山和印度班加罗尔--(美国商业资讯)--工程智能解决方案与工程研发(ER&D)咨询服务领域的全球领导者L&T Technology Services Limited (BSE: 540115, NSE: LTTS)今...

0评论2026-07-161835

Esri 助力 Google Maps 与 Waze 实时更新道路封闭信息
ArcGIS 用户现可将道路封闭信息共享至更多消费级导航应用,助力提升驾驶者出行体验 Esri 已扩展其社区地图计划,使 ArcGIS 用户能够直接向 Google Maps 和 Waze 共享实时道路封闭信息。 目前,全球已有超过 100 个社区通过 Esri 社区地图计划提供权威的道路封闭数据。 ArcGIS 道路封闭解决方案帮助政府部门绘制并发布因道路施工、大型活动及突发事件造成的道路封闭信息,并将其共享至消费级导航应用。 与 Waze for Cities 的集成实现了双...

0评论2026-07-161325

Neuraptive Therapeutics獲得聖路易華盛頓大學創新生物可吸收神經刺激技術授權
賓夕法尼亞州賈斯特布魯克--(美國商業資訊)--專注於周圍神經損傷治療的臨床階段生物科技公司Neuraptive Therapeutics, Inc.今日宣布,已與聖路易華盛頓大學(WashU)簽署獨家授權合約,獲得一項生物可吸收無線電子神經刺激裝置技術的獨家授權。 該技術由WashU醫學院研究人員與美國西北大學合作研發,可透過向受損神經精準輸送電脈波,加快神經再生。該裝置採用完全生物可吸收設計,可在人體內自然降解,無需接受後續手術進行取出。 WashU副校長兼技術管理辦公室董事總經...

0评论2026-07-161600

牛津经济研究院新研究揭示酒吧的社会与经济影响
该报告由AB InBev委托发布,探讨了世界各地的人们如何通过酒吧建立联系和构建社群 伦敦--(美国商业资讯)--根据牛津经济研究院(Oxford Economics)的最新研究,酒吧是全球各地社区重要的社会和经济贡献者。这项由AB InBev委托进行的研究考察了酒吧在五个全球市场——巴西、墨西哥、韩国、英国和美国——的经济和社会影响。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/new...

0评论2026-07-161218

Kinaxis Inc.将于2026年8月6日召开2026年第二季度财报电话会议
渥太华,安大略省--(美国商业资讯)--端到端供应链规划与协调领域的全球领先企业 Kinaxis® Inc.(TSX:KXS)今日宣布,公司已安排召开电话会议,以讨论截至2026年6月30日的第二季度财务业绩。本次电话会议将于2026年8月6日星期四东部时间上午8:30举行,由首席执行官Razat Gaurav和财务规划与分析副总裁Peter Yaraskavitch主持,随后将进行问答环节。公司将于2026年8月5日星期三股市收盘后公布第二季度财务业绩。 ...

0评论2026-07-161895

European Commission Approves Erbitux (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation
ERBITUX in combination with encorafenib and FOLFOX is the first and only approved targeted regimen for the first-line treatment of adult patients with BRAF V600E-mutant mCRC The approval is based on the pivotal Phase 3 BREAKWATER trial, which demonst...

0评论2026-07-161830

Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
Ministry of Health of the Republic of Indonesia Grants Plasma Fractionation License, Enabling Takeda to Collect and Fractionate Plasma as Part of Multi-Phased Initiative Takeda Will Initially Invest up to 30 Million U.S. Dollars to Begin the Establis...

0评论2026-07-161023

Samos Energy Acquisition Corporation宣布完成2.3亿美元首次公开募股
纽约--(美国商业资讯)-- Samos Energy Acquisition Corporation(以下简称“公司”)今日宣布,已圆满完成首次公开募股(“IPO”),共发行23,000,000个单位,其中包括承销商全额行使超额配售选择权,额外认购3,000,000个单位。本次发行的定价为每单位10.00美元,公司因此获得总募集资金230,000,000美元。 这些单位于2026年7月10日在纽约证券交易所(New York Stock ...

0评论2026-07-161375